VivePeptides logo

Research Use Only

Peptides for Anxiety

Neuropeptides studied in the context of anxiolytic signaling, GABA modulation, and the stress response.

Peptides for Anxiety are research compounds studied for their capacity to modulate neurotransmitter systems and stress-response pathways implicated in anxiety-related signaling. This category features Selank, a tuftsin-derived peptide investigated for GABAergic modulation, and Semax, an ACTH analog studied for neuropeptide-driven HPA axis and neurotrophic factor effects. All compounds are intended for preclinical and in vitro research use only.

Reviewed by the VivePeptides Research DeskLast reviewed

Research Catalog

Compounds in this collection

Selank research peptide vial

Selank

$60.00View
Semax research peptide vial

Semax

$50.00View

Research Overview

Anxiety Peptides Research: What This Category Encompasses

The anxiety peptides research category encompasses synthetic neuropeptides investigated for their roles in modulating stress-related signaling pathways in preclinical models. This is an active area of inquiry because anxiety-related neurological mechanisms involve multiple interacting systems, including GABAergic inhibition, HPA axis regulation, and neurotrophic factor expression.

Two primary compounds represent this space at VivePeptides: Selank, a heptapeptide analog of the immunomodulatory peptide tuftsin, has been studied for its capacity to influence GABA-A receptor activity and upregulate BDNF expression in rodent models. Semax, a synthetic analog of ACTH(4-7), has been investigated for its effects on HPA axis signaling and neuroprotective gene expression under stress conditions.

VivePeptides supplies both compounds at research-grade purity with accompanying certificates of analysis, supporting investigators who require documented quality standards for study reproducibility and regulatory compliance in preclinical settings.

Two Distinct Mechanism Classes

Selank operates through GABAergic and neurotrophic signaling pathways, while Semax is investigated through neuropeptide receptor-mediated HPA axis modulation. Researchers select between them based on which neurological axis their study is designed to interrogate.

Batch-Specific Purity Documentation

VivePeptides provides certificates of analysis for each lot of Selank and Semax, enabling investigators to verify identity and purity prior to use. Documented quality standards are a practical requirement for study reproducibility and protocol traceability in preclinical research settings.

Cold-Chain Handling Requirements

Both Selank and Semax require cold-chain storage to preserve peptide integrity across the duration of a study. Researchers should follow reconstitution and aliquoting protocols established in the preclinical literature to maintain compound stability between experimental sessions.

Mechanism & Research Context

Mechanism Classes and Preclinical Research Context

What distinguishes the mechanism classes in this collection is the divergence between direct GABAergic modulation, as seen with Selank, and neuropeptide-driven transcriptional effects, as characterized in Semax research. Preclinical literature has examined Selank primarily in rodent open-field and elevated-plus-maze paradigms, where GABAergic potentiation and BDNF upregulation have been reported as central mechanistic candidates.

Semax studies have focused on HPA axis modulation and ACTH-receptor binding, with additional investigation into BDNF and NGF expression under induced stress conditions. Researchers selecting between these compounds typically do so based on the signaling pathway of primary interest: GABAergic inhibition versus neuropeptide receptor-mediated transcriptional responses.

Practical study design considerations include route of administration conventions documented in the literature, the stability profiles of each peptide under laboratory storage conditions, and the assay endpoints most sensitive to each mechanism class. Both compounds require standard cold-chain handling and should be reconstituted per established protocols.

Research FAQ

Frequently asked questions

What are peptides for anxiety investigated for in research?

Peptides in the anxiety research category are investigated for their capacity to modulate neurotransmitter systems and stress-response pathways in preclinical models, not for clinical or therapeutic application in humans or animals. Compounds such as Selank and Semax represent distinct mechanism classes: GABAergic modulation and neuropeptide-driven HPA axis signaling, respectively. All such compounds are supplied for in vitro and preclinical laboratory research use only.

What is Selank and what mechanism class is it associated with?

Selank is a synthetic heptapeptide analog of the immunomodulatory peptide tuftsin, studied for its interactions with GABAergic signaling pathways in preclinical anxiety models. Research has examined its capacity to potentiate GABA-A receptor activity and to influence BDNF expression in rodent behavioral paradigms. It is a research compound intended for laboratory use and is not formulated or approved for human or veterinary application.

What is Semax and how does its mechanism class differ from Selank?

Semax is a synthetic analog of the adrenocorticotropic hormone fragment ACTH(4-7), and its mechanism class centers on neuropeptide receptor-mediated signaling and HPA axis modulation rather than direct GABAergic activity. Preclinical investigations have examined its influence on BDNF and NGF expression under stress conditions, distinguishing it from GABAergic compounds like Selank. Researchers select between these two based on which signaling axis is the primary focus of their study design.

How do researchers typically choose between Selank and Semax for an anxiety-related study?

Researchers typically choose between Selank and Semax based on the neurological signaling pathway under primary investigation. Studies focused on GABAergic inhibition or GABA-A receptor-mediated BDNF upregulation tend to align with Selank, while studies examining HPA axis regulation or neuropeptide receptor-mediated transcriptional responses are more commonly designed around Semax. Both compounds have documented preclinical literature that informs assay endpoint selection and route of administration conventions.

What purity and documentation standards should researchers expect for anxiety research peptides?

Research-grade anxiety peptides should be supplied with a certificate of analysis confirming purity, identity, and lot-specific quality data to support reproducibility in preclinical studies. VivePeptides provides batch-specific certificates of analysis for both Selank and Semax. These documentation standards are important for investigators who must demonstrate compound traceability and quality in their published study protocols.

What are the storage and handling requirements for Selank and Semax?

Both Selank and Semax require cold-chain storage conditions to maintain peptide integrity prior to use in laboratory research. Lyophilized forms are generally stable at lower temperatures, and reconstituted solutions should be handled according to protocols established in the preclinical literature for each compound. Researchers should consult product documentation for specific storage temperature ranges and recommended reconstitution solvents to ensure compound stability across their study timeline.

Related Research Collections

Continue exploring

Nootropic and Cognitive PeptidesPeptides for SleepPeptides for Weight LossGLP-1 Peptides

All products are sold strictly for laboratory and scientific research use only. Not for human or animal consumption, diagnostic, or therapeutic use. Nothing on this page constitutes medical advice or a health claim.